Skip to content
Biodatica
Start free

Investigator

Eric Collisson

FRED HUTCHINSON CANCER CENTER · funded by NCI

Companies
1

Resolved onto their grants.

Grants
4

Federal awards on file.

Non-dilutive funding
$1.6M

Summed across those awards.

First award
Jan 1, 1997

Latest Apr 1, 2021.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R01

    Understanding efficacy and FE(II)-Promoted Activation of 1,2,4-Trioxolanes in cancer

    $661k

    Apr 1, 2021NCIFRED HUTCHINSON CANCER CENTERNIH RePORTER · 11143196 (opens the source filing in a new tab)

  2. R01

    Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy

    $1

    Apr 1, 2021NCIFRED HUTCHINSON CANCER CENTERNIH RePORTER · 11193860 (opens the source filing in a new tab)

  3. R01

    Optimizing Pancreatic Cancer Management with Next Generation Imaging and Liquid Biopsy

    $544k

    Apr 1, 2021NCIFRED HUTCHINSON CANCER CENTERNIH RePORTER · 11331308 (opens the source filing in a new tab)

  4. P30

    Cancer Basic Biology

    $401k

    Jan 1, 1997NCIFRED HUTCHINSON CANCER CENTERNIH RePORTER · 11303321 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources